Polymyxin B Hemoperfusion for Sepsis and Septic Shock: A Systematic Review and Meta-Analysis

Surgical Infections

Volumn 18, Issue 3, 2017, Pages 225-233

  Terayama, Takero ^a   Yamakawa, Kazuma ^a   Umemura, Yutaka ^b   Aihara, Morio ^c   Fujimi, Satoshi ^a  

^a OSAKA GENERAL MEDICAL CENTER   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

Author keywords

hemoperfusion; meta analysis; mortality; polymixin B; systematic review

Indexed keywords

POLYMYXIN B; ANTIINFECTIVE AGENT;

ADULT; ADVERSE OUTCOME; CLINICAL EFFECTIVENESS; DRUG EFFICACY; DRUG SAFETY; EFFECT SIZE; EVIDENCE BASED MEDICINE; HEMATOLOGY EQUIPMENT; HEMOPERFUSION; HIGH RISK PATIENT; HUMAN; META ANALYSIS; MORTALITY RATE; MORTALITY RISK; MULTICENTER STUDY (TOPIC); POLYMYXIN B IMMOBILIZED FIBER; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPSIS; SEPTIC SHOCK; SURVIVAL; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; HEMOPERFUSION; HUMANS; POLYMYXIN B; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEPSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 85017363814     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2016.168     Document Type: Review

References (29)

1. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013;369:840-851
2. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013;39:165-228
3. Marshall JC, Foster D, Vincent JL, et al. Diagnostic and prognostic implications of endotoxemia in critical illness: Results of the MEDIC study. J Infect Dis 2004;190:527-534
4. Nakamura T, Ebihara I, Shoji H, et al. Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: Decrease in plasma levels of soluble P-selectin, platelet factor 4 and b-thromboglobulin. Inflamm Res 1999;48:171-175
5. Nemoto H, Nakamoto H, Okada H, et al. Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis. Blood Purif 2001;19:361-369
6. Suzuki H, Nemoto H, Nakamoto H, et al. Continuous hemodiafiltration with polymyxin-B immobilized fiber is effective in patients with sepsis syndrome and acute renal failure. Ther Apher 2002;6:234-240
7. Cruz DN, Antonelli M, Fumagalli R, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 2009;301: 2445-2452
8. Payen DM, Guilhot J, Launey Y, et al. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: A multicenter randomized control trial. Intensive Care Med 2015;41:975-984
9. Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011;64: 383-394
10. Aihara M. GRADE System for Clinical Practice Guideline, 2nd ed [in Japanese]. Hirosaki: Toppan Media, 2015
11. GRADEpro Guideline Development Tool [Software]. McMaster University (developed by Evidence Prime, Inc). 2015. www.gradepro.org
12. Nakamura T, Matsuda T, Suzuki Y, et al. Polymyxin Bimmobilized fiber hemoperfusion in patients with sepsis. Dial Transplant 2003;32:602-609
13. Vincent JL, Laterre PF, Cohen J, et al. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intraabdominal infection. Shock 2005;23:400-405
14. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;20;5:13
15. Aoki H, Kodama M, Tani T, et al. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber. Am J Surg 1994;167:412-317
16. Tani T, Hanasawa K, Endo Y, et al. The efficiency and limit of endotoxin absorbing therapy on the multiple organ failure. ICU and CCU 1995;19:797-804
17. Shimaoka H, Nakada K, Atagi K, et al. The efficacy of endotoxin absorbing therapy. ICU and CCU 1996;20: 693-698
18. Shoji H, Tani T, Hanasawa K, et al. Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: Designing and antiendotoxin efficacy in the clinical application. Ther Apher 1998;2:3-12
19. Tani T, Hanasawa K, Endo Y, et al. Therapeutic apheresis for septic patients with organ dysfunction: Hemoperfusion using a polymyxin B-immobilized column. Artif Organs 1998;22:1038-1044
20. Iwama H, Komatsu T. Effect of an endotoxin-removing column containing immobilized polymyxin B fiber in a patient withe septic shock from gram-positive infection. Acta Anaesthesiol Scand 1998;42:590-593
21. Kawamata T, Imaizumi H, Yoshida M, et al. Polymyxin Bimmobilized fiber improves hemodynamic state in MRSA septic patients. Intensive Care Med 1997;23:130-131
22. Ono S, Tsujimoto H, Matsumoto A, et al. Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber. Am J Surg 2004;188:150-156
23. Tani T, Hanasawa K, Kodama M, et al. Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 activities in septic patients. World J Surg 2001;25:660-668
24. Ikeda T, Ikeda K, Nagura M, et al. Clinical evaluation of PMX-DHP for hypercytokinemia caused by septic multiple organ failure. Ther Apher Dial 2004;8:293-298
25. Kushi H, Miki T, Okamaoto K, et al. Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Crit Care 2005;9:R653-R661
26. Stevenson EK, Rubenstein AR, Radin GT, et al. Two decades of mortality trends among patients with severe sepsis A comparative meta-analysis. Crit Care Med. 2014;42: 625-631
27. Cruz DN, Perazella MA, Bellomo R, et al. Effectiveness of polymyxin B-immobilized fiber column in sepsis: A systematic review. Crit Care 2007;11:R47
28. Qiu XH, Liu SQ, Guo FM, et al. A meta-analysis of the effects of direct hemoperfusion with polymyxin B-immobilized fiber on prognosis in severe sepsis. Zhonghua Nei Ke Za Zhi 2011;50:316-321
29. Zhou F, Peng Z, Murugan R, et al. Blood purification and mortality in sepsis: A meta-analysis of randomized trials. Crit Care Med 2013;41:2209-2220